干酪乳杆菌LC2W表面黏附相关蛋白的提取与鉴定

目的提取和鉴定干酪乳杆菌LC2W表面黏附相关蛋白,初步探索LC2W对胃癌细胞MKN-45细胞的黏附机制。方法LiCl处理、Sephadex G-75柱层析分离提取LC2W的表面蛋白,用黏附试验、电镜观察和SDS-PAGE电泳进行黏附相关蛋白的鉴定。结果LC2W经LiCl处理后,扫描电镜结果发现菌体表面粗糙但仍完整,黏附试验表明其对MKN-45细胞的黏附能力显著降低。提取到的表面蛋白的分子量分别为41.6、63.5、66.2 kDa。粗提物经柱层析后发现分子量为41.6 kDa的组分可以明显增强经LiCl处理过的菌体的黏附,而与未经处理的菌体黏附情况类似。结论表面蛋白参与了LC2W对MKN-45细胞的黏附,其主要活性成分的分子量为41.6 kDa。     

H.pylori抗体鸡蛋制品对H.pylori感染BALB/c小鼠的实验研究

目的通过幽门螺杆菌(Helicobacter pylori,H.pylori)标准株的接种,建立BALB/c小鼠感染H.pylori胃炎动物模型,评价H.pylori抗体鸡蛋制品对小鼠感染性胃炎的预防效果。方法将灭活的H.pylori国际标准菌株(NCTC 11637)作为抗原,对产蛋鸡进行免疫。免疫后收集鸡蛋,对达到效价的鸡蛋,无菌采集卵黄。BALB/c小鼠60只,适应性喂养1周后,随机分为5组,Ⅰ组为胃炎模型组,Ⅱ组为生理盐水组,Ⅲ、IV、V组分别为低剂量、中剂量和高剂量卵黄抗体组,每组12只。Ⅰ组予H.pylori菌液灌胃造模,Ⅱ组先予生理盐水灌胃后再予H.pylori菌液灌胃对照,Ⅲ、IV、V组分别用不同剂量抗H.pylori卵黄抗体灌胃后再予H.pylori菌液灌胃造模。小鼠均于距最后一次灌胃后8周全部处死,用微需氧细菌培养检测H.pylori定植;HE染色观察小鼠胃黏膜病理组织学改变。结果在接种H.pylori后第8周,Ⅰ组和Ⅱ组小鼠胃内均有大量H.pylori定植,感染率为91.7%,Ⅲ组的感染率是58.3%,IV和V组的感染率均小于30%。结论 H.pylori抗体鸡蛋制品可以抑制BALB/c小鼠感染H.pylori,抗体的保护作用与抗体的剂量呈正相关。     

营养因子对干酪乳杆菌LC2W胞外多糖合成的影响

针对影响干酪乳杆菌LC2W产胞外多糖的主要营养因子:葡萄糖、酪蛋白胨和酵母提取物进行了单因素及正交试验,确定了合成胞外多糖的最适组成为葡萄糖60 g/L,酪蛋白胨16 g/L ,酵母提取物10 g/L,其中酪蛋白胨影响差异极显著.验证试验表明,以优化后的培养基进行发酵试验,37 ℃培养24 h,所得胞外多糖量为120.37 mg/L,较原来提高67.97 %.     

干酪乳杆菌LC2W细胞壁组分对RAW264．7巨噬细胞吞噬活性的影响

目的探讨干酪乳杆菌LC2W细胞壁组分体外对小鼠巨噬细胞功能的影响。方法以培养液单纯培养小鼠巨噬细胞系RAW264．7细胞作为对照,研究干酪乳杆菌LC2W细胞壁主要组分磷壁酸和肽聚糖对RAW264．7细胞乳酸脱氢酶（LDH）活性、吞噬中性红和致病菌能力的影响。结果不同浓度磷壁酸和肽聚糖对小鼠巨噬细胞RAW264．7细胞LDH活性、吞噬中性红能力有明显增强作用,并呈一定的剂量效应。在相同质量浓度时,2种细胞壁组分刺激RAW264．7细胞吞噬中性红能力差异无显著性,但磷壁酸对巨噬细胞RAW264．7细胞内LDH活性的增强作用高于肽聚糖。在受到浓度为50μg/ml的磷壁酸和肽聚糖刺激后,磷壁酸和肽聚糖均能显著增强RAW264．7对致病性大肠埃希菌和肠炎沙门菌的吞噬作用（P〈0．01）。经过刺激的巨噬细胞与致病菌共孵育1h后,其吞噬能力达到最大值。结论干酪乳杆菌LC2W细胞壁主要组分磷壁酸和肽聚糖可以增强小鼠巨噬细胞RAW264．7细胞内LDH活性及吞噬能力,并具有剂量效应。     

不同碳源对干酪乳杆菌LC2W胞外多糖组成影响的研究

运用紫外光谱、红外光谱、HPLC和气相色谱对葡萄糖和乳糖两种碳源获得的胞外多糖(EPS)单一组分G1、G2和L1、L2的结构进行了初步分析。结果显示不同碳源对EPS的分子结构、分子量和单糖组成都有影响。紫外光谱分析都不含蛋白和核酸;红外光谱分析G1、G2和L1、L2均呈现多糖的特征峰,但波形、特征吸收波段、波峰强度有些差异;HPLC测定G1、G2、L1和L2的平均分子量分别为6.65×105Da、1.01×104Da、2.25×106Da和1.36×104Da;气相色谱分析G1、G2和L1、L2的主要单糖组成摩尔比分别为:鼠李糖∶葡萄糖∶半乳糖=3.07∶3.29∶1;鼠李糖∶葡萄糖∶半乳糖=2.84∶6.4∶1;甘露糖∶葡萄糖∶半乳糖=17.24∶6.03∶1;甘露糖∶葡萄糖∶半乳糖=28.71∶5.98∶1。     

H.pylori尿素酶B亚单位在保加利亚乳杆菌的表达与鉴定

目的构建表达幽门螺杆菌（Helicobacter pylori,H、pylori）尿素酶B亚单位（UreB）的基因工程乳杆菌,并对其进行初步的安全性评估。方法采用高保真PCR从H.pylori标准菌株NCTC 11637中扩增ureB基因,插入乳酸菌表达质粒pMG36e,将重组质粒电转入保加利亚乳杆菌L6032中,获得表达ureB的基因工程乳杆菌。在含乳糖的MRS培养基诱导目的蛋白表达,Western blot鉴定其免疫原性。连续传代培养60代,检测基因工程乳杆菌的稳定性、形态学与生理生化特性以进行初步的安全性评估。结果特异PCR、酶切和测序鉴定均证实ureB基因克隆入表达载体pMG36e,SDS-PAGE结果显示,重组质粒pMG36e-ureB电转入保加利亚乳杆菌所构建的基因工程乳杆菌能表达约64KD的蛋白,Western blot证明该蛋白能与抗H.priori ureB的兔血清反应。稳定性、形态学与生理生化特性检测结果表明,基因工程乳杆菌与原始菌株保加利亚乳杆菌完全一致。结论成功构建能表达H.pylori UreB的保加利亚乳杆菌L6032-UreB,该基因工程菌在形态与生理生化特性上未发生任何变异,从而为探索幽门螺杆菌感染的益生菌制剂调理疗法奠定了坚实的基础。     

干酪乳杆菌LC2W对胃上皮细胞的粘附性质及其与菌体表面性质的关系

目的研究干酪乳杆菌LC2W对胃上皮细胞MKN-45的粘附性质,探讨粘附与其表面性质的关系,初步判断粘附素的性质。方法通过化学和酶处理LC2W细胞壁表面成分,测定其粘附性质、表面性质的变化,并通过相关性分析粘附与表面性质的关系。结果氯化锂、胃蛋白酶、蛋白酶K、苯酚和热处理能显著降低LC2W的粘附性,表明表面的相关蛋白类物质可能参与了LC2W对MKN-45细胞的粘附。化学和酶处理后疏水能力和自聚合能力的变化也表明表面蛋白类物质的存在。相关性分析发现粘附能力分别与疏水性和自聚合能力呈现强正线型相关,证明蛋白类成分在粘附过程中发挥作用。结论 LC2W的表面粘附素是一种蛋白类物质。     

H.pylori-L型对胃癌BGC-823细胞侵袭力影响的研究

目的研究幽门螺杆菌L型(Helicobacter pyloriL-form,H.pylori-L型)感染对胃癌BGC-823细胞侵袭力影响,探讨H.pylori-L型在胃癌发展中的作用和可能机制。方法将胃癌BGC-823细胞与H.pylori-L型按1:50、1:200和1:500的不同比例共培养24 h,进行以下实验:(1)应用具有聚碳酸酯和重建基底膜的Transwell小室细胞侵袭模型,观察与H.pylori-L型作用后胃癌BGC-823细胞的侵袭能力;(2)应用Western-blotting实验测定胃癌BGC-823细胞OPN和MMP2蛋白表达量的变化。结果 (1)Transwell侵袭实验发现随着胃癌BGC-823细胞与H.pylo-ri-L型细菌的浓度比例增大,胃癌BGC-823细胞穿透重建基底膜的数量逐渐增多,穿透重建基底膜的胃癌细胞数量在不同实验组之间的差异有统计学意义(F=24.78,P0.01);(2)Western-blotting实验发现,随着胃癌BGC-823细胞与H.pylori-L型比例增大,胃癌BGC-823细胞中OPN和MMP2的表达量逐渐增加,呈细菌浓度依赖性。结论 H.pylori-L型感染增强胃癌细胞的侵袭能力,具有细菌浓度依赖效应,其机制可能与其上调了胃癌细胞OPN、MMP2表达有关。     

Strain-dependent proliferation in response to human gastric mucin and adhesion properties of Helicobacter pylori are not affected by co-isolated Lactobacillus sp

Background: Helicobacter pylori colonize the mucus layer that covers the gastric epithelium and can cause gastritis, ulcers, and gastric cancer. Recently, Lactobacillus sp. have also been found to reside in this niche permanently. This study compares adhesive properties and proliferation of co‐isolated lactobacilli and H. pylori in the presence of mucins and investigates possibilities for lactobacilli‐mediated inhibition of H. pylori. Materials and methods: Binding and proliferation of four H. pylori and four Lactobacillus strains, simultaneously isolated after residing in the stomachs of four patients for >4 years, to human gastric mucins were investigated using microtiter‐based methods. Results: The H. pylori strains co‐isolated with lactobacilli exhibited the same mucin binding properties as demonstrated for H. pylori strains previously. In contrast, no binding to mucins was detected with the Lactobacillus strains. Proliferation of mucin‐binding H. pylori strains was stimulated by the presence of mucins, whereas proliferation of non‐binding H. pylori and Lactobacillus strains was unaffected. Associative cultures of co‐isolated H. pylori and Lactobacillus strains showed no inhibition of H. pylori proliferation because of the presence of whole bacteria or supernatant of lactobacilli. Conclusions: The presence of lactobacilli in the stomach did not select for different mucin binding properties of H. pylori, and Lactobacillus sp. did neither compete for binding sites nor inhibit the growth of co‐isolated H. pylori. The effects of human gastric mucins on H. pylori proliferation vary between strains, and the host–bacteria interaction in the mucus niche thus depends on both the H. pylori strain and the microenvironment provided by the host mucins.     

Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri

We examined the competition of binding of Lactobacillus reuteri and Helicobacter pylori to gangliotetraosylceramide (asialo-GM1) and sulfatide which are putative glycolipid receptor molecules of H. pylori, and identified a possible sulfatide-binding protein of the L. reuteri strain. Among nine L. reuteri strains, two (JCM1081 and TM105) were shown to bind to asialo-GM1 and sulfatide, and to inhibit binding of H. pylori to both glycolipids by a thin layer chromatogram-overlay assay using biotin-labeled bacterial cells. The extract from the bacterial cells of strain TM105 with several detergents, including octyl beta-D-glucopyranoside, retained binding to both glycolipids and also inhibited H. pylori binding, suggesting that a binding inhibitor(s) is associated with the bacterial cell surface. When the cell extract was applied to the agarose gel immobilized galactose 3-sulfate corresponding to the structure of sugar moieties of sulfatide, an approximately 47-kDa protein was found to bind to the gel. This observation strongly suggested that inhibition by selected L. reuteri strains help to prevent infection in an early stage of colonization in H. pylori and proposed that L. reuteri strains sharing glycolipid specificity with H. pylori have a potential as probiotics.     

Reduction of Overall Helicobacter pylori Colonization Levels in the Stomach of Mongolian Gerbil by Lactobacillus johnsonii La1 (LC1) and Its in Vitro Activities against H. pylori Motility and Adherence

The effects of Lactobacillus johnsonii La1 (LC1) on Helicobacter pylori colonization in the stomach were investigated. H. pylori colonization and gastritis in LC1-inoculated Mongolian gerbils were significantly less intense than those in the control animals. LC1 culture supernatant (>10-kDa fraction) inhibited H. pylori motility and induced bacterial aggregation in human gastric epithelial cells, suggesting the potential of clinical use of LC1 product.     

Stimulation of adhesion molecule expression by Helicobacter pylori and increased neutrophil adhesion to human umbilical vein endothelial cells

Helicobacter pylori upregulates endothelial adhesion molecules but the pattern is unclear. Human umbilical vein endothelial cells (HUVEC) were exposed to control medium or H. pylori 60190. Binding of monoclonal antibodies against P-selectin, E-selectin, vascular adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) was determined using enzyme-linked immunosorbent assay. Binding of polymorphonuclear leukocytes to HUVEC was determined on cells exposed as above. After 6 h exposure to H. pylori, there were 30%, 124%, 167% and 100% increases in P-selectin, E-selectin, VCAM-1 and ICAM-1 levels and a 400% increase in polymorphonuclear leukocyte adhesion in HUVEC exposed to H. pylori. Effects of incubation for other intervals between 0 and 18 h are also described. H. pylori exerts some of its effects on gastric mucosa via gastric vasculature. This study gives insight into the pattern of H. pylori-associated endothelial adhesion molecule upregulation.     

The effect of ascorbic acid on Helicobacter pylori induced cyclooxygenase 2 expression and prostaglandin E2 production by gastric epithelial cells in vitro

BACKGROUND: Cyclooxygenase 2 (COX-2) is induced by the presence of Helicobacter pylori (H. pylori) on the gastric mucosa as part of the inflammatory response; this results in the synthesis of prostaglandins that amplify the local inflammatory response. The presence of H. pylori inhibits the secretion of ascorbate into the gastric lumen. Interestingly, ascorbate inhibits the growth of H. pylori and low dietary levels are associated with an increased risk of gastric adenocarcinoma. We therefore investigated the effect of ascorbate on H. pylori mediated COX-2 induction and prostaglandin production in vitro. METHODS: H. pylori was cocultured with gastric epithelial cells in the presence of ascorbate at physiological concentrations. The expression of COX-2 was assessed by Western blotting and prostaglandin E(2) (PGE(2)) was assessed by ELISA. RESULTS: Ascorbate inhibited gastric cell PGE(2) synthesis but not in COX-2 expression in response to H. pylori. In the absence of the organism, ascorbate also reduced PGE(2) expression in cells that constitutively express COX-2, again with no reduction of COX-2 protein expression. CONCLUSIONS: Physiological concentrations of ascorbate inhibit PGE(2) but not COX-2 expression in response to H. pylori in gastric epithelial cells.     

Expression of CEACAM1 or CEACAM5 in AZ‐521 cells restores the type IV secretion deficiency for translocation of CagA by Helicobacter pylori

Helicobacter pylori represents an important pathogen involved in diseases ranging from gastritis, peptic ulceration, to gastric malignancies. Prominent virulence factors comprise the vacuolating cytotoxin VacA and the cytotoxin‐associated genes pathogenicity island (cagPAI)‐encoded type IV secretion system (T4SS). The T4SS effector protein CagA can be translocated into AGS and other gastric epithelial cells followed by phosphorylation through c‐Src and c‐Abl tyrosin kinases to hijack signalling networks. The duodenal cell line AZ‐521 has been recently introduced as novel model system to investigate CagA delivery and phosphorylation in a VacA‐dependent fashion. In contrast, we discovered that AZ‐521 cells display a T4SS incompetence phenotype for CagA injection, which represents the first reported gastrointestinal cell line with a remarkable T4SS defect. We proposed that this deficiency may be due to an imbalanced coexpression of T4SS receptor integrin‐β₁ or carcinoembryonic antigen‐related cell adhesion molecules (CEACAMs), which were described recently as novel H. pylori receptors. We demonstrate that AZ‐521 cells readily express integrin‐β₁, but overexpression of integrin‐β₁ constructs did not restore the T4SS defect. We further show that AZ‐521 cells lack the expression of CEACAMs. We demonstrate that genetic introduction of either CEACAM1 or CEACAM5, but not CEACAM6, in AZ‐521 cells is sufficient to permit injection and phosphorylation of CagA by H. pylori to degrees observed in the AGS cell model. Expression of CEACAM1 or CEACAM5 in infected AZ‐521 cells was also accompanied by tyrosine dephosphorylation of the cytoskeletal proteins vinculin and cortactin, a hallmark of H. pylori‐infected AGS cells. Our results suggest the existence of an integrin‐β₁‐ and CEACAM1‐ or CEACAM5‐dependent T4SS delivery pathway for CagA, which is clearly independent of VacA. The presence of two essential host protein receptors during infection with H. pylori represents a unique feature in the bacterial T4SS world. Further detailed investigation of these T4SS functions will help to better understand infection strategies by bacterial pathogens.